CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome-Reference-Cited by-同舟云学术

CIGB-300 anticancer peptide regulates the protein kinase CK2-dependent phosphoproteome

Published:2020-05-13 Issue:1-2 Volume:470 Page:63-75
ISSN:0300-8177
Container-title:Molecular and Cellular Biochemistry
language:en
Short-container-title:Mol Cell Biochem

Author:

Perera Yasser^ORCID,Ramos Yassel,Padrón Gabriel,Caballero Evelin,Guirola Osmany,Caligiuri Lorena G.,Lorenzo Norailys,Gottardo Florencia,Farina Hernán G.,Filhol Odile,Cochet Claude,Perea Silvio E.

Funder

This work was conducted with the financial support of the CIGB-300 Grant, Biomedical Research Division, CIGB, Cuba.

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Clinical Biochemistry,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11010-020-03747-1.pdf

Reference49 articles.

1. Salvi M, Cesaro L, Pinna LA (2010) Variable contribution of protein kinases to the generation of the human phosphoproteome: a global weblogo analysis. Biomol Concepts 1(2):185–195. https://doi.org/10.1515/bmc.2010.013

2. Ruzzene M (1804) Pinna LA (2010) Addiction to protein kinase CK2: A common denominator of diverse cancer cells? Biochim Biophys Acta (BBA) Proteins Proteom 3:499–504

3. Barata JT (2011) The impact of PTEN regulation by CK2 on PI3K-dependent signaling and leukemia cell survival. Adv Enzyme Regul 51(1):37–49. https://doi.org/10.1016/j.advenzreg.2010.09.012

4. Scaglioni PP, Yung TM, Cai LF et al (2006) A CK2-dependent mechanism for degradation of the PML tumor suppressor. Cell 126:269–283

5. Di Maira G, Salvi M, Arrigoni G et al (2005) Protein kinase CK2 phosphorylates and upregulates Akt/PKB. Cell Death Differ 12:668–677

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “Phosphoproteomic quantification based on phosphopeptide intensity or occupancy? An evaluation based on casein kinase 2 downstream effects”;Journal of Proteomics;2024-09

2. Diastereomers of the anticancer peptide CIGB-300 with altered b-turn structures;2024-07-19

3. Recent Advances in the Discovery of CK2 Inhibitors;ACS Omega;2024-05-03

4. Scoping Pleiotropy of CK2 in Musculoskeletal Disorders for a Novel Targeting Approach;Kinases and Phosphatases;2024-01-31

5. CK2 Chemical Probes: Past, Present, and Future;Kinases and Phosphatases;2023-11-01